Our reporting exposed a broken system in which rebate schemes appear to drive market share for Remicade and its biosimilar competitors.Download
Analysis of select corporate transcripts through the lens of Joseph Harrington’s landmark paper, “Collusion in Plain Sight: Firms’ use of Public Announcements to Restrain Competition.”Download
Our content provides subscribers with unique insight and breaking news regarding the most complex mergers and regulatory situations around the world.Inquire
Our work combines cutting edge breaking news with in-depth analysis to better inform readers how policy and regulation affects market competition.Learn More
Our editorial team reconstructs the policy process to yield market insight for a community of subscribers including government regulators, lawyers, investors, and non-profits.Learn More
Security screening company Evolv Technology (EVLV) may be overstating the...
Sep 22, 2023
In its acquisition of utility company Dominion (D), Enbridge (ENB), a major...
Sep 22, 2023
UnitedHealth/Emis review sparks third party complaints. The Competition and...
Sep 18, 2023
On the latest episode of Second Request, Associate Professor of Law Matthew...
Sep 15, 2023
On this episode of Second Request, Teddy Downey and the FTC’s Shaoul Sussman...
Aug 03, 2023
We are an investigative news organization providing our subscribers with detail-oriented reporting on antitrust, merger control, corporate investigations, and energy issues.
“I appreciate the helpful work done by The Capitol Forum. It’s one of the sources I turn to for information about what activity is out there not only in the antitrust space, but also in the consumer protection world.”
“I have become an avid reader of The Capitol Forum because it provides timely in-depth news and analysis of the myriad legal, business, legislative and political factors affecting business developments. I always come away with fresh perspectives that help me advise my clients about current issues.”
“I eagerly read every report from The Capitol Forum and have great admiration for its reporters and editors. I find it to be the single best source of up-to-the-minute coverage and objective in-depth analysis of cutting-edge antitrust news and other critical competition-related developments.”
“The Capitol Forum’s news and analysis is spot on and reflects a perfect mix of investigative reporting, independent research, and expert opinion.”
“The Capitol Forum provides an always interesting and sometimes surprising look under the hood about pending antitrust activities.”
“The Capitol Forum is the only team covering this incredibly important beat. Better yet, their work is deeply intelligent, influential, and almost always right.”
“The Capitol Forum consistently provides timely and sophisticated news and analysis of important M & A transactions. It’s the real deal!”
“The Capitol Forum has been an indispensable resource for me in analyzing regulatory risk affecting companies in my portfolio or watch list.”
Sep 15, 2023
Aug 29, 2023
Aug 18, 2023
Analysis of select corporate transcripts through the lens of Joseph Harrington’s landmark paper, “Collusion in Plain Sight: Firms’ use of Public Announcements to Restrain Competition.”
Get an inside view of the biologics market, where rebate schemes appear to drive market share. You’ll learn how a complex system supports sluggish biosimilar uptake and other types of anticompetitive conduct.